Abstract
Longitudinal monitoring of GR expression in plasma-derived EVs from patients with prostate cancer treated with androgen signaling inhibitors facilitates early detection of acquisition of resistance to androgen receptor signaling inhibition in individual patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have